SCHEMBL34470168

SCHEMBL34470168

Cn1cc(C(=O)O)cc1-c1ccc(C2(NC(=O)OC(C)(C)C)CC2)c(F)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGLN2 Q96KS0 1/20 0.35
▸ AKT1 P31749 2/20 0.34
▸ P2RY14 Q15391 2/20 0.33
▸ GSK3B P49841 1/20 0.33
▸ DYRK1A Q13627 1/20 0.33
▸ CYP17A1 P05093 1/20 0.33
▸ KIT P10721 1/20 0.32
▸ DPP8 Q6V1X1 2/20 0.32
▸ DPP9 Q86TI2 2/20 0.32
▸ PDE2A O00408 2/20 0.32
▸ CNR2 P34972 2/20 0.32
▸ CNR1 P21554 1/20 0.32
▸ AKT2 P31751 1/20 0.31
▸ RXRA P19793 1/20 0.31
▸ RXRB P28702 1/20 0.31
▸ MAPT P10636 1/20 0.31
▸ MMP13 P45452 1/20 0.31
▸ TRPA1 O75762 1/20 0.30
▸ NR1H2 P55055 1/20 0.30
▸ BDKRB1 P46663 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL34469480 0.94 EGLN2 (0.34) EGLN2AKT1P2RY14GSK3BDYRK1A
SCHEMBL34469743 0.91 EGLN2 (0.34) EGLN2AKT1GSK3BDYRK1ACYP17A1
SCHEMBL34469923 0.87 EGLN2 (0.33) EGLN2AKT1CYP17A1KITDPP8
SCHEMBL34469978 0.85 AKT1 (0.43) AKT1P2RY14GSK3BDYRK1AKIT
SCHEMBL34469566 0.81 AKT1 (0.43) AKT1P2RY14GSK3BDYRK1AKIT
SCHEMBL34469946 0.79 AKT1 (0.42) AKT1P2RY14GSK3BDYRK1AKIT
SCHEMBL34469468 0.76 AKT1 (0.43) AKT1P2RY14GSK3BDYRK1AKIT
SCHEMBL34470019 0.75 AKT1 (0.42) AKT1P2RY14GSK3BDYRK1AKIT
SCHEMBL34469447 0.75 AKT1 (0.36) EGLN2AKT1P2RY14PDE2ACNR2
SCHEMBL5517439 0.74 AAK1 (0.45) DPP8DPP9PDE2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026090477-A1 HELICASE INHIBITORS AND USES THEREOF KIMIA THERAPEUTICS, INC. (US) 2026-04-30 — — WO disclosed
Send feedback